A transgender woman incarcerated in a federal prison sits alone in her cell, reflecting the growing controversy over policies that could force transgender inmates off hormone therapy under Executive Order 14168. (Image generated by ChatGPT using DALL·E, 2026.)
Executive Order 14168, issued on January 20, 2025 and titled Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government, has reshaped how transgender people are treated by federal institutions. While much public discussion has centered on gender markers or legal recognition of transgender identity, one of the most immediate and dangerous consequences of the order has emerged inside the federal prison system. In particular, policy changes following the order have led to attempts by federal prison authorities to discontinue hormone therapy and other gender-affirming medical treatments for incarcerated transgender people. For many transgender inmates, this policy shift represents not only a denial of identity but also a serious threat to physical and psychological health. At the same time, the logic behind these policies raises broader concerns about how transgender people may be treated by federal institutions beyond the prison system.
The executive order directs federal agencies to recognize only two sexes—male and female—defined as immutable and determined at conception (The White House, 2025). This directive eliminates gender identity as a category recognized in federal administration. When applied to the federal prison system, the policy affects how prisoners are classified, housed, and treated medically. Most critically, it has been used to justify attempts to eliminate or restrict gender-affirming healthcare for incarcerated transgender people.
Gender-affirming hormone therapy is widely recognized by major medical organizations as a necessary treatment for individuals diagnosed with gender dysphoria. Medical consensus holds that hormone therapy can significantly reduce psychological distress, depression, and suicide risk among transgender patients. Within prison environments—where individuals already face isolation, stress, and restricted autonomy—continuity of medical care is considered especially important. Nevertheless, following the issuance of Executive Order 14168, federal prison officials moved to halt or restrict such treatment.
Reporting by the Associated Press indicates that the policy shift prompted the Federal Bureau of Prisons to attempt to terminate or suspend hormone therapy for transgender inmates in federal custody (Riccardi & Kunzelman, 2025). The decision sparked immediate legal challenges from incarcerated transgender individuals who argued that the abrupt withdrawal of medically prescribed treatment would cause severe harm. In multiple cases, courts were asked to intervene to prevent the termination of hormone therapy.
In June 2025, a federal judge ruled that the Bureau of Prisons must continue providing hormone therapy to transgender inmates while litigation proceeds. Reuters journalist Nate Raymond reported that the court found the government had failed to justify abruptly ending treatment that physicians had previously deemed medically necessary (Raymond, 2025). The ruling emphasized that forcing transgender prisoners to discontinue hormone therapy could produce serious psychological consequences and potentially violate constitutional protections against cruel and unusual punishment.
Despite these court rulings, recent reporting suggests that federal prison policies continue to move toward restricting gender-affirming care. In March 2026, Samantha Riedel reported in Them that federal prison authorities had begun implementing policies requiring transgender inmates receiving hormone therapy to gradually discontinue those medications (Riedel, 2026). According to medical experts cited in the report, forced withdrawal from hormone therapy can lead to severe depression, anxiety, and increased risk of self-harm. For individuals who have relied on hormone therapy for years as part of a medically supervised transition, being forced off treatment can trigger profound physical and psychological distress.
These medical risks are particularly concerning in correctional environments. Prison systems already struggle with high rates of mental health crises, and incarcerated individuals frequently have limited access to specialized medical care. When transgender inmates are forced off hormone therapy, the resulting psychological distress can be intensified by the conditions of confinement, including isolation, stigma, and lack of support networks. The loss of hormone therapy can also have visible physical effects that may expose transgender prisoners to additional harassment or violence from other inmates.
Although these developments are occurring within federal prisons, the implications extend beyond incarcerated populations. Policies implemented within prisons often reflect broader ideological frameworks that can shape how government agencies treat marginalized groups more generally. When federal policy defines sex as immutable and rejects the legitimacy of gender identity, that definition may influence how transgender people are treated across a wide range of institutions, including healthcare systems, identification programs, and federal employment policies.
The attempt to eliminate hormone therapy for transgender prisoners demonstrates how quickly policy can shift from symbolic definitions to control over medical care and bodily autonomy. If federal institutions can deny gender-affirming treatment to incarcerated individuals based on a policy redefining sex, similar arguments could potentially be used to justify restrictions in other contexts. While prisoners occupy a uniquely vulnerable position under government authority, policies affecting them can serve as testing grounds for broader administrative approaches.
History offers numerous examples in which policies applied first to prisoners or other marginalized groups later expand into wider legal frameworks. In the case of Executive Order 14168, the removal of gender identity from federal policy raises concerns that transgender people may face increasing barriers to medical care and legal recognition across multiple institutions. For transgender Americans, the developments within federal prisons therefore represent more than a correctional policy dispute; they signal how federal authority may increasingly regulate transgender bodies and identities.
The ongoing legal challenges surrounding hormone therapy in federal prisons will play a significant role in determining the future of transgender healthcare within federal institutions. Courts must decide whether the abrupt withdrawal of medically necessary treatment constitutes deliberate indifference to serious medical needs, which could violate the Eighth Amendment’s prohibition on cruel and unusual punishment. The outcome of these cases will shape not only the lives of transgender prisoners but also the broader legal landscape governing transgender rights in the United States.
Executive Order 14168 has therefore created a situation in which the treatment of transgender inmates has become a focal point in a larger struggle over recognition, medical care, and bodily autonomy. The attempt to force transgender prisoners off hormone therapy illustrates how administrative policy decisions can translate into immediate and profound consequences for vulnerable individuals. At the same time, it raises deeper questions about how far such policies might extend and what they could mean for transgender people beyond prison walls.
References
Raymond, N. (2025, June 3). U.S. judge says federal prisons must continue hormone therapy for transgender inmates. Reuters. https://www.reuters.com/legal/us-judge-orders-prisons-continue-hormone-therapy-transgender-inmates
Riccardi, N., & Kunzelman, M. (2025, January 23). What to know about President Donald Trump’s order targeting transgender rights. Associated Press. https://apnews.com/article/trump-transgender-passports-prisons-eggs-sperm-da1d1d280658a8c85c57cfec2f30cefb
Riedel, S. (2026, March 10). Federal prisons are beginning to force trans inmates off hormone therapy. Them. https://www.them.us/story/federal-prisons-are-beginning-to-force-trans-inmates-off-hormone-therapy
The White House. (2025). Executive Order 14168: Defending women from gender ideology extremism and restoring biological truth to the federal government. https://public-inspection.federalregister.gov/2025-02090.pdf
The recent announcement from the Office of Personnel Management (OPM) that gender-affirming health care will be excluded from the Federal Employees Health Benefits (FEHB) and Postal Service Health Benefits (PSHB) programs beginning in 2026 represents a profound step backward in civil rights and health equity. Under this directive, chemical and surgical interventions for gender transition will no longer be covered, though counseling for gender dysphoria must remain available. Insurance carriers are required to develop exceptions processes for individuals currently undergoing such care, yet the parameters of those processes remain undefined. Providers of gender-affirming care are also barred from being listed in plan directories, effectively discouraging access (Office of Personnel Management, 2025; Moss, 2025).
Transgender Pornography Is Performance, Not Representation
By Katherine Walter
On July 16, 2026
In adult films
A stylized editorial composition pairs bold typography with filmmaking imagery, including a director’s chair under studio lights, to emphasize the essay’s central argument that transgender pornography is a staged form of entertainment rather than a representation of transgender lives. The image underscores the distinction between commercial fantasy and lived experience while affirming that supporting transgender pornography is compatible with recognizing its representational limitations. (Image generated by ChatGPT using DALL·E, 2026.)
Whenever people discuss transgender pornography, I think it’s important to begin with an honest admission: I support transgender pornography. I don’t believe there is anything inherently wrong with consenting adults creating or consuming adult content. Sex work is work, performers deserve respect, and transgender performers deserve the same autonomy over their bodies and careers as anyone else.
At the same time, I think we need to be honest about what transgender pornography is—and what it isn’t.
Pornography is entertainment. It is staged. It is directed. It is edited. It is created to satisfy an audience. It has never been an accurate representation of how people actually live, love, or experience their sexuality.
Transgender pornography is no different.
For decades, the largest commercial market for transgender pornography has been cisgender men. Like every successful entertainment industry, producers have responded to the desires of their customers. The stories, camera work, performers, marketing, and even the terminology used have largely been shaped by what sells to that audience.
That doesn’t make transgender pornography bad.
It simply means we shouldn’t mistake it for a documentary about transgender lives.
As a transgender woman myself, I often find that mainstream transgender pornography doesn’t speak to me. That’s not because I object to pornography—quite the opposite. It’s because so much of it is produced through the lens of what cisgender men find appealing rather than what transgender women themselves might find authentic, relatable, or emotionally engaging.
I would love to see more transgender pornography created by transgender people, for transgender audiences, or at least with our perspectives in mind. Stories that reflect our relationships, our intimacy, our humor, our vulnerability, and the many different ways we experience attraction and desire.
Instead, much of the industry revolves around familiar commercial formulas. Performers become fantasy figures rather than complete people. The focus is on creating a particular erotic experience for the viewer, not portraying the diversity of transgender lives.
Again, that isn’t unique to transgender pornography.
Mainstream heterosexual pornography is not an accurate depiction of heterosexual relationships. Lesbian pornography produced for straight men often bears little resemblance to the lived experiences of many lesbians. Gay pornography is designed to entertain its audience, not to document everyday gay life. Every genre emphasizes fantasy over realism.
Transgender pornography follows the same commercial model.
The problem arises when people have little or no real-life interaction with transgender people and pornography becomes their primary source of information. They begin to assume that what they see on screen reflects how transgender women generally look, behave, think, or approach relationships.
It doesn’t.
Porn performers are actors. Scenes are planned. Directors make creative choices. Editing removes awkward moments. Bodies are selected because they fit a particular aesthetic. The finished product is designed to arouse viewers—not to educate them about transgender people.
That’s why it’s important to separate fantasy from reality.
Transgender women are as varied as any other group of people. We are professionals, students, artists, parents, veterans, athletes, scientists, retail workers, and everything in between. Some of us enjoy making pornography. Most of us do not. Our identities cannot be reduced to a category on an adult website.
Supporting transgender pornography and recognizing its limitations are not contradictory positions.
I can appreciate adult entertainment while also acknowledging that it is a commercial product built around audience demand. I can celebrate the performers while recognizing that the industry’s priorities do not necessarily reflect the experiences of transgender women as a whole.
Pornography is performance.
The sooner people understand that, the easier it becomes to appreciate it for what it is—fantasy created for entertainment—without confusing it for a realistic portrait of an entire community.